Suppr超能文献

热处理KM2发酵对肠道微生物群结构的安全性及影响评估

Evaluation of the Safety and Impact of Heat-Treated KM2 Fermentation on Gut Microbiome Architecture.

作者信息

Won Seok, Jeong Yejin, Kim Ji-Eun, Kim Jong-Hoon, Song Hyun Soo, Bae Hyun-Hwa, Kwak Mi-Sun, Kim Don-Kyu, Sung Moon-Hee, Kwak Suryang

机构信息

Department of Bio and Fermentation Convergence Technology, College of Science and Technology, Kookmin University, Seoul 02707, Republic of Korea.

Microbiome Technology Research Institute, Kookmin Bio, Seoul 02826, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2024 Dec 27;35:e2411069. doi: 10.4014/jmb.2411.11069.

Abstract

Postbiotics, bioactive compounds from the fermentation process by probiotics, are gaining attention for their potential health benefits as safer alternatives to live probiotic microbes. is a well-studied probiotic species known for promoting gut health and immune modulation. However, the safety and effects of its postbiotic formulations on the gut microbiome structure remain less explored. This study presents a randomized, double-blind, placebo-controlled human study of KLP-KM2, a postbiotic consisting of heat-treated KM2 fermentation complex, in elderly participants. Over 12 weeks, KLP-KM2 consumption did not result in noticeable adverse reaction cases compared to the placebo. Nevertheless, the gut microbial diversity and taxonomic architecture of the KLP-KM2 recipients were differentiated from those of the placebo recipients after 12 weeks. A notable outcome was the increase in the number of subjects carrying spp., which contributed to the distinct gut microbiome profiles observed between the two groups. Interestingly, KLP-KM2 facilitated the de novo colonization of spp. in subjects who had not harbored these bacteria at the baseline. These results suggest the potential of KLP-KM2 as a safe and effective postbiotic intervention to enhance energy metabolism and mobility in older adults.

摘要

后生元是益生菌发酵过程中产生的生物活性化合物,作为活的益生菌微生物的更安全替代品,因其潜在的健康益处而受到关注。 是一种经过充分研究的益生菌,以促进肠道健康和免疫调节而闻名。然而,其后生元制剂对肠道微生物群结构的安全性和影响仍有待进一步探索。本研究针对老年参与者开展了一项关于KLP-KM2的随机、双盲、安慰剂对照人体研究,KLP-KM2是一种由热处理的KM2发酵复合物组成的后生元。在12周的时间里,与安慰剂相比,服用KLP-KM2并未导致明显的不良反应病例。然而,12周后,接受KLP-KM2的受试者的肠道微生物多样性和分类结构与接受安慰剂的受试者有所不同。一个显著的结果是携带 spp.的受试者数量增加,这导致了两组之间观察到的不同肠道微生物群特征。有趣的是,KLP-KM2促进了在基线时未携带这些细菌的受试者中 spp.的从头定殖。这些结果表明,KLP-KM2作为一种安全有效的后生元干预措施,具有增强老年人能量代谢和活动能力的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/11813362/6ca657c89a30/jmb-35-e2411069-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验